Your session is about to expire
← Back to Search
Tonsillectomy and Dilaudid + Tylenol for Postoperative Pain
Study Summary
This trial will help doctors determine the best post-tonsillectomy pain medication regimen to minimize pain and help patients have a quicker recovery.
- Postoperative Pain
- Postoperative Nausea and Vomiting
- Postoperative Hemorrhage
- Weight Changes
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there still vacancies for volunteers in this experiment?
"According to information on clinicaltrials.gov, this medical project is not currently open for recruitment as the most recent update was made in October 2017. However, there are a plethora of other studies that require participants at present."
To what ailments is the combination of Tonsillectomy, Dilaudid and Tylenol commonly recommended?
"Tonsillectomy and the combination of Dilaudid with Tylenol are both effective treatments for ailments such as catarrh, rhinorrhoea, and musculoskeletal pain."
Has there been any additional research conducted on the combination of Tonsillectomy and Dilaudid plus Tylenol?
"Currently, there are 114 clinical trials underway for Tonsillectomy and Dilaudid + Tylenol. Out of these active studies, 32 have entered phase 3. Although the majority take place in Boston, Massachusetts, 1033 locations throughout the nation offer this treatment option to patients."
What is the uppermost capacity of patients allowed to join this medical experiment?
"This study has ceased patient search as of October 18th, 2017. If you are seeking other trials to take part in, 1087 studies related to postoperative hemorrhage and 114 involving Tonsillectomy and Dilaudid + Tylenol are presently recruiting patients."
Has the FDA authorized Tonsillectomy and Dilaudid + Tylenol for use?
"Our team at Power assigned a 3 out of 3 rating to the safety profile for Tonsillectomy and Dilaudid + Tylenol, as this is an approved Phase 4 trial."
Share this study with friends
Copy Link
Messenger